Beauty Health (NASDAQ:SKIN – Get Free Report) and Adagio Medical (NASDAQ:ADGM – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, dividends, risk, profitability, analyst recommendations and institutional ownership.
Earnings & Valuation
This table compares Beauty Health and Adagio Medical”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Beauty Health | $398.00 million | 0.54 | -$100.12 million | ($0.42) | -4.12 |
| Adagio Medical | N/A | N/A | -$2.13 million | N/A | N/A |
Adagio Medical has lower revenue, but higher earnings than Beauty Health.
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Beauty Health | 1 | 3 | 1 | 0 | 2.00 |
| Adagio Medical | 0 | 0 | 0 | 0 | 0.00 |
Beauty Health currently has a consensus target price of $2.55, indicating a potential upside of 47.40%. Given Beauty Health’s stronger consensus rating and higher possible upside, equities analysts plainly believe Beauty Health is more favorable than Adagio Medical.
Institutional & Insider Ownership
93.3% of Beauty Health shares are held by institutional investors. Comparatively, 48.1% of Adagio Medical shares are held by institutional investors. 41.0% of Beauty Health shares are held by insiders. Comparatively, 53.5% of Adagio Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Profitability
This table compares Beauty Health and Adagio Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Beauty Health | -8.11% | -44.83% | -3.54% |
| Adagio Medical | N/A | 160.59% | 40.99% |
Volatility & Risk
Beauty Health has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500. Comparatively, Adagio Medical has a beta of 0.12, indicating that its stock price is 88% less volatile than the S&P 500.
Summary
Beauty Health beats Adagio Medical on 6 of the 11 factors compared between the two stocks.
About Beauty Health
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
About Adagio Medical
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company’s product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. The company is based in Laguna Hills, California.
Receive News & Ratings for Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.
